FibeRio Technology Corporation announces today the launch of its new generation of Forcespinning equipment specifically designed to meet the production needs of fine fiber media producers and converters.
Applied Materials, Inc. today announced it collaborated with Samsung Electronics Co., Ltd. and PSK Inc., a Korea-based leader in photoresist removal, to develop an advanced patterning solution for the manufacture of future generations of NAND and DRAM device designs.
At the upcoming Printed Electronics USA 2014 Show, SouthWest NanoTechnologies, Inc. will demonstrate and discuss the use of carbon nanotube inks as a superior material for certain touch capacitance and membrane switch replacement applications.
XEI Scientific Inc. announces the release of the Evactron EP. This provides a new approach to plasma cleaning designed for those in the physics and materials science communities building and using custom-designed vacuum systems.
The specific aim of a newly funded twelve month long project is to explore the possibility of using composites, featuring high grade graphene, to produce fixed dental prostheses with markedly increased longevity and improved clinical function.
PIE Scientific has recently released a revolutionary downstream plasma cleaner - SEMI-KLEEN plasma cleaner. It is designed to meet the toughest contamination requirements from the semiconductor capital equipment industry.
PinPoint Nanomechanical acquires images simultaneously and in real-time by taking the high speed force-distance curves when the XY scanner stops, while maintaining well defined control of contact force and contact time between the tip and the sample.
Nanolive SA, a start-up company founded last year at the EPFL Innovation Park in Lausanne, Switzerland, has developed a revolutionary microscope which, for the very first time, allows the exploration of a living cell in 3D without damaging it.
NanoHybrids, Inc., an emerging biotech company developing nanotechnology-based clinical and pre-clinical solutions, was recently awarded a Small Business Innovation Research (SBIR) contract grant to develop a targeted biocompatible imaging contrast agent that will help detect high risk atherosclerotic plaques.